Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke Journal of Cerebral Blood Flow & Metabolism advance online publication, February 11 2015. doi:10.1038/jcbfm.2015.17 Authors: Vladimer Darsalia, Martin Larsson, David Nathanson, Thomas Klein, Thomas Nyström & Cesare Patrone

http://feeds.nature.com/~r/jcbfm/rss/aop/~3/8zJWkmm5Vyw/jcbfm.2015.17

Source: Journal of Cerebral Blood Flow - February 11, 2015 Category: Neurology Authors: Vladimer DarsaliaMartin LarssonDavid NathansonThomas KleinThomas NyströmCesare Patrone Tags: diabetes DPP-4 inhibitors exendin-4 GLP-1 liraglutide neuroprotection stroke Source Type: research

More News: Diabetes | Endocrinology | Neurology | Stroke | Victoza